ArticleResearch (Washington, D.C.)2026
A "Detachable Polyanionic Protective Shell" Enveloping Photodynamic Cationic Nanoassemblies for Keratitis Treatment.
Article in Research (Washington, D.C.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bacterial keratitis is a rapidly progressive, invasive corneal infection, necessitating the urgent development of more effective antibacterial therapies. Cationic polymers, which exert bactericidal effects by disrupting bacterial membranes, represent a promising candidate; however, their clinical application is limited by cytotoxicity associated with their positive charge. Here, we proposed a "detachable polyanionic protective shell (DPPS)" strategy to shield the positive charges of cationic polymers. Specifically, the quaternary ammonium salt (QAS)-modified polylysine was co-assembled with the photosensitizer chlorin e6 (Ce6) to obtain nanoassemblies (PQC), and then the PQC was encapsulated with polythioctic acid (PTA) to form DPPS, obtaining PQCT with functional adaptability. PQCT maintains a net negative charge under physiological conditions with good biocompatibility. In a bacterial infection environment, the reactive oxygen species (ROS) produced by Ce6 under laser irradiation will cause PTA to break bonds and degrade, DPPS to crack and be removed, the net charge of the nano-assembly to change from negative to positive, and QAS exposed to exert bactericidal functions with ROS. Both in vitro and in vivo studies demonstrated the outstanding antibacterial performance of PQCT after laser irradiation, particularly in the treatment of bacterial keratitis. This work presents a safe and effective strategy for targeted bacterial infection therapy.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.